facebook

When after surgery would enhancement typically be performed?

3 min read

The timing of enhancement following ICL surgery is governed by a single clinical principle: the refraction must be stable before a second surgical intervention is planned. Laser enhancement applied to a refractive state that has not fully settled will produce an outcome that is accurate at the time of surgery but inaccurate once the eye reaches its final equilibrium. Premature enhancement replaces one refractive error with another. ¹

At Blue Fin Vision®, enhancement is not considered until the refraction has been documented as stable for a minimum of three to four months following primary ICL surgery. This period allows for the resolution of any surgically induced oedema, the stabilisation of corneal curvature, and the settling of the effective lens position. Only once two consecutive refractions over this interval are concordant – and the residual error meets the functional and dioptric thresholds – is enhancement planning initiated. ²

The three-to-four-month window is a minimum, not a target. Patients who show refractive variability beyond this period are observed until stability is confirmed, however long that requires. The clinical cost of waiting longer than necessary is negligible; the clinical cost of enhancing prematurely is a second error requiring a third procedure. ³

Patients should confirm this timeline at their consultation – and be cautious of practices that offer enhancement at six to eight weeks, which is not consistent with evidence-based refractive practice.

References

  1. Ganesh S, Brar S. Clinical outcomes of phakic intraocular lens implantation for the correction of high myopia with three years of follow-up. Clin Ophthalmol. 2013;7:2011–2021. PMID: 24204123.
  2. Packer M. Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens. Clin Ophthalmol. 2016;10:1059–1077. PMID: 27390517.
  3. Kamiya K, Shimizu K, Igarashi A, Komatsu M. Four-year follow-up of posterior chamber phakic intraocular lens implantation for moderate to high myopia. Arch Ophthalmol. 2009;127(7):845–850. PMID: 19597104.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.